BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36408783)

  • 1. Retinopathy of prematurity.
    Dammann O; Hartnett ME; Stahl A
    Dev Med Child Neurol; 2023 May; 65(5):625-631. PubMed ID: 36408783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retinopathy of Prematurity - Update on Classification, Screening, and Therapy].
    Li JQ; Kellner U; Lorenz B; Stahl A; Krohne TU
    Klin Monbl Augenheilkd; 2022 Mar; 239(3):346-363. PubMed ID: 35253129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF).
    Tsai AS; Chou HD; Ling XC; Al-Khaled T; Valikodath N; Cole E; Yap VL; Chiang MF; Chan RVP; Wu WC
    Prog Retin Eye Res; 2022 May; 88():101018. PubMed ID: 34763060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current update on retinopathy of prematurity: screening and treatment.
    Chen J; Stahl A; Hellstrom A; Smith LE
    Curr Opin Pediatr; 2011 Apr; 23(2):173-8. PubMed ID: 21150442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Educational paper: Retinopathy of prematurity.
    Casteels I; Cassiman C; Van Calster J; Allegaert K
    Eur J Pediatr; 2012 Jun; 171(6):887-93. PubMed ID: 22052209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor.
    Barry GP; Yu Y; Ying GS; Tomlinson LA; Lajoie J; Fisher M; Binenbaum G;
    Ophthalmology; 2021 Aug; 128(8):1188-1196. PubMed ID: 33387554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Classification of Retinopathy of Prematurity, Third Edition.
    Chiang MF; Quinn GE; Fielder AR; Ostmo SR; Paul Chan RV; Berrocal A; Binenbaum G; Blair M; Peter Campbell J; Capone A; Chen Y; Dai S; Ells A; Fleck BW; Good WV; Elizabeth Hartnett M; Holmstrom G; Kusaka S; Kychenthal A; Lepore D; Lorenz B; Martinez-Castellanos MA; Özdek Ş; Ademola-Popoola D; Reynolds JD; Shah PK; Shapiro M; Stahl A; Toth C; Vinekar A; Visser L; Wallace DK; Wu WC; Zhao P; Zin A
    Ophthalmology; 2021 Oct; 128(10):e51-e68. PubMed ID: 34247850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
    Cayabyab R; Ramanathan R
    Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinopathy of Prematurity: A Global Perspective and Recent Developments.
    Sabri K; Ells AL; Lee EY; Dutta S; Vinekar A
    Pediatrics; 2022 Sep; 150(3):. PubMed ID: 35948728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinopathy of Prematurity: Pathogenesis and Current Treatment Options.
    Quimson SK
    Neonatal Netw; 2015; 34(5):284-7. PubMed ID: 26802829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk.
    Adams GG; Bunce C; Xing W; Butler L; Long V; Reddy A; Dahlmann-Noor AH
    BMJ Open; 2017 Mar; 7(3):e013366. PubMed ID: 28325857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of retinopathy of prematurity.
    Smith LE
    Semin Neonatol; 2003 Dec; 8(6):469-73. PubMed ID: 15001119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurovascular abnormalities in retinopathy of prematurity and emerging therapies.
    Dai C; Xiao J; Wang C; Li W; Su G
    J Mol Med (Berl); 2022 Jun; 100(6):817-828. PubMed ID: 35394143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics.
    Ryu J
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study.
    Good WV; Hardy RJ; Dobson V; Palmer EA; Phelps DL; Quintos M; Tung B;
    Pediatrics; 2005 Jul; 116(1):15-23. PubMed ID: 15995025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review.
    Kandasamy Y; Hartley L; Rudd D; Smith R
    Br J Ophthalmol; 2017 Jan; 101(1):21-24. PubMed ID: 27388246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of VEGF Inhibition in the Treatment of Retinopathy of Prematurity.
    Eldweik L; Mantagos IS
    Semin Ophthalmol; 2016; 31(1-2):163-8. PubMed ID: 26959143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights in diagnosis and treatment for Retinopathy of Prematurity.
    Cernichiaro-Espinosa LA; Olguin-Manriquez FJ; Henaine-Berra A; Garcia-Aguirre G; Quiroz-Mercado H; Martinez-Castellanos MA
    Int Ophthalmol; 2016 Oct; 36(5):751-60. PubMed ID: 26767656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New therapeutic approaches in the treatment of retinopathy of prematurity].
    Jandeck C
    Klin Monbl Augenheilkd; 2009 Nov; 226(11):914-20. PubMed ID: 19798624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update in the Treatment of Retinopathy of Prematurity.
    Bancalari A; Schade R
    Am J Perinatol; 2022 Jan; 39(1):22-30. PubMed ID: 32544962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.